Is COYA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for COYA. It does not provide personalized investment advice.

COYA (Coya Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Coya Therapeutics, Inc. Common Stock (COYA) is a publicly traded Healthcare sector company. As of October 5, 2026, COYA trades at $4.87 with a market cap of $112.83M and a P/E ratio of -4.91. COYA moved +0.00% today. Year to date, COYA is -17.07%; over the trailing twelve months it is -18.06%. Its 52-week range spans $3.71 to $8.29. Analyst consensus is strong buy with an average price target of $15.33. Rallies surfaces COYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are COYA's key financials?

COYA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. COYA recently traded at $4.87. Market cap is $112.83M. P/E ratio is -4.91. Revenue is $3.55M.

COYA Key Metrics

Key financial metrics for COYA
Metric	Value
Price	$4.87
Market Cap	$112.83M
P/E Ratio	-4.91
EPS	$-0.98
Dividend Yield	0.00%
52-Week High	$8.29
52-Week Low	$3.71
Volume	5.19K
Avg Volume	0
Revenue (TTM)	$3.55M
Net Income	$-14.88M
Gross Margin	0.00%

COYA Analyst Consensus

3 analysts cover COYA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.33.

Common questions about COYA

What are COYA's key financials?: COYA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. COYA recently traded at $4.87. Market cap is $112.83M. P/E ratio is -4.91. Revenue is $3.55M.
Is COYA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for COYA. It does not provide personalized investment advice.